Full text is available at the source.
Abstract
Clinical outcomes were evaluated in obese patients with psoriatic arthritis (PsA) over 6 months.
- Patients who started tirzepatide alongside biologic therapy may experience different clinical outcomes compared to those who began biologic therapy alone.
- The evaluation focuses specifically on patients with obesity and PsA, highlighting a specific subgroup.
- Outcomes assessed include various clinical parameters relevant to the management of PsA.
Simplified